<DOC>
	<DOCNO>NCT00318240</DOCNO>
	<brief_summary>This feasibility study determine safety ability HIFU ( High Intensity Focused Ultrasound ) selectively destroy prostate cancer tissue men demonstrate local recurrence prostate cancer follow radiation treatment .</brief_summary>
	<brief_title>Prostate Cancer Treatment Following Radiation Failure With High Intensity Focused Ultrasound ( HIFU )</brief_title>
	<detailed_description>This feasibility study determine safety ability HIFU ( High Intensity Focused Ultrasound ) selectively destroy prostate cancer tissue men demonstrate local recurrence prostate cancer follow radiation treatment . All participant receive treatment HIFU monitor closely recurrence disease ( ) , quality life adverse event .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>· Male patient initial presentation organ confine recurrent prostate cancer ( clinical Stages T1 T2 ) treat external beam radiation therapy brachytherapy subsequently biopsyproven local recurrence . Age &gt; 40 year &lt; 80 year . Anesthesia Surgical Assignment ( ASA ) categories I , II III . Negative radionuclide bone scan within 3 month prior HIFU treatment rule possibility metastasis . PSA level &gt; 0.5ng/ml &lt; 10ng/ml . Preradiation Gleason score &lt; 8 Clearly imageable prostate TRUS Written inform consent . · T3 T4 prostate cancer . Age &lt; 40 year . &gt; 80 year . ASA IV high . Gleason score &gt; 8 . PSA &lt; 0.5ng/ml &gt; 10ng/ml . Prostate size &gt; 40 gram determine transrectal ultrasound Large calcification area treat ( &gt; 5mm ) . Bleeding disorder determine abnormal prothrombin time ( INR ) partial thromboplastin time ( PTT ) . Patient Coumadin anticoagulant , unless anticoagulation temporarily reverse stop . Urinary tract infection unless treat satisfactorily antibiotic document sterile urine culture . Interest future fertility . History allergy latex . Inability visualize prostatic tissue adequately transrectal ultrasound image . Currently hormonal therapy prostate cancer ( patient enrol come hormone therapy 3 month ) . History treatment prostate cancer , brachytherapy external beam radiation . History TURP , thermotherapy urethral stent . History major rectal surgery . History inflammatory bowel disease . History urinary bladder neck contracture . History malignancy skin cancer .</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>High Intensity Focused Ultrasound</keyword>
	<keyword>Men</keyword>
	<keyword>Locally recurrent prostate cancer .</keyword>
</DOC>